Scott Tarriff, President and CEO at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 16,245 shares at $75.12 ($1.2M) on 2015-09-01, disclosed to the SEC on 2015-09-03.
Scheduled sale ($1.2M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.12 | 49 | $4K | 0.3% |
| 2 | $76.09 | 1,878 | $143K | 11.4% |
| 3 | $76.88 | 11,792 | $907K | 72.5% |
| 4 | $77.93 | 2,526 | $197K | 15.7% |
| Total | $76.95 avg | 16,245 | $1.2M | 100% |
| Filing → |
| EGRX | SELL | 2023-05-18 | $300K | — | Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-04-03 | $2.5M | — | Filing → |